318 related articles for article (PubMed ID: 26045820)
1. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.
Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL
Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.
Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
J Hematol Oncol; 2015 May; 8(1):57. PubMed ID: 27391317
[TBL] [Abstract][Full Text] [Related]
8. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
J Hematol Oncol; 2015 May; 8():50. PubMed ID: 25966845
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma.
Fu C; Xu X; Lu W; Nie L; Yin T; Wu D
Medicine (Baltimore); 2019 Oct; 98(42):e17412. PubMed ID: 31626095
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma.
Zhao Y; Kong CQ; Ye JZ; Bai T; Luo T; Wang D; Chen M; Wang HF; Wang XB; Liu JJ; Chen J; Luo HL; Li LQ
Med Sci Monit; 2019 Aug; 25():6539-6546. PubMed ID: 31472071
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
[TBL] [Abstract][Full Text] [Related]
13. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
Mo M; Liu S; Ma X; Tan C; Wei L; Sheng Y; Song Y; Zeng X; Huang D; Qiu X
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma.
Tu ZQ; Li RJ; Mei JZ; Li XH
Int J Clin Exp Pathol; 2014; 7(7):4303-9. PubMed ID: 25120813
[TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
Liu Z; Chang Q; Yang F; Liu B; Yao HW; Bai ZG; Pu CS; Ma XM; Yang Y; Wang TT; Guo W; Zhou XN; Zhang ZT
Eur J Surg Oncol; 2017 Sep; 43(9):1697-1703. PubMed ID: 28732670
[TBL] [Abstract][Full Text] [Related]
17. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
18. Expression of lncRNA TCONS_00027978 in hepatocellular carcinoma and its influence on prognosis and survival.
Chen Q; Tian GD; Wang CC
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5655-5660. PubMed ID: 29271999
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in hepatocellular carcinoma.
Lan T; Chang L; Wu L; Yuan Y
Mol Med Rep; 2016 Nov; 14(5):4606-4612. PubMed ID: 27748842
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
